Medtronic Commends CMS on Proposed Rule to Expand Medicare Coverage for All CGMs

On October 27th, the Centers for Medicare & Medicaid Services (CMS) announced proposed new changes that, if finalized, would expand Medicare coverage for Continuous Glucose Monitors (CGMs) that provide critical information on glucose levels to help people with diabetes better manage their disease. We are very encouraged by CMS’s proposed rule and commend the agency on taking action to help more people with diabetes. We strongly believe this proposal puts patients first and empowers them to choose the therapies that best meet their diabetes management needs. Importantly, the proposed rule, if finalized, could enable continuity of therapy for people on certain Medtronic insulin pump systems transitioning into Medicare — including Medtronic hybrid closed loop systems which automatically adjust insulin delivery based on readings from the integrated CGM.

We know how important CGM access is to our customers. To support those without CGM insurance coverage, including our Medicare customers, we recently launched our CGM Access Discount program to help those who do not have insurance coverage for Medtronic CGM. This program was launched to address the significant need we heard from customers and through this program, we’re able to make our CGM much more accessible. We are encouraged that a longer-term solution may be available to help these customers and look forward to continued engagement with CMS and other stakeholders to continue advocating on behalf of those living with diabetes.

Customers interested in our CGM Access Discount program can call 1-800-646-4633 ext. 21629 (M-F, 8 AM – 6 PM CT) to find out if they’re eligible.